{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:45:50Z","timestamp":1792197950101,"version":"4.4.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T00:00:00Z","timestamp":1725926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002473","name":"Dongshin University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002473","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.biopha.2024.117440","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T18:23:35Z","timestamp":1726770215000},"page":"117440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Therapeutic effect and molecular mechanism of the ultra-low molecule compound K on multiple myeloma"],"prefix":"10.1016","volume":"180","author":[{"given":"Young Eun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Ran","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0372-9185","authenticated-orcid":false,"given":"Myung Geun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9686","key":"10.1016\/j.biopha.2024.117440_bib1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0140-6736(09)60221-X","article-title":"Multiple myeloma","volume":"374","author":"Raab","year":"2009","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.biopha.2024.117440_bib2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5045\/br.2021.2021187","article-title":"Twenty-year incidence trend of hematologic malignancies in the Republic of Korea: 1999-2018","volume":"56","author":"Park","year":"2021","journal-title":"Blood Res."},{"issue":"1","key":"10.1016\/j.biopha.2024.117440_bib3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jgr.2017.09.001","article-title":"Systems-level mechanisms of action of Panax ginseng: a network pharmacological approach","volume":"42","author":"Park","year":"2018","journal-title":"J. Ginseng Res."},{"issue":"2","key":"10.1016\/j.biopha.2024.117440_bib4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3892\/ijo.2017.4054","article-title":"The ginsenoside metabolite compound K inhibits growth, migration and stemness of glioblastoma cells","volume":"51","author":"Lee","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2024.117440_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13040487","article-title":"Ginsenoside absorption rate and extent enhancement of black ginseng (CJ EnerG) over red ginseng in healthy adults","volume":"13","author":"Yoo","year":"2021","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.biopha.2024.117440_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/biom10071028","article-title":"Ginsenoside compound K: insights into recent studies on pharmacokinetics and health-promoting activities","volume":"10","author":"Sharma","year":"2020","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.biopha.2024.117440_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1475-2867-13-24","article-title":"Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells","volume":"13","author":"Chen","year":"2013","journal-title":"Cancer Cell Int."},{"issue":"12","key":"10.1016\/j.biopha.2024.117440_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e12106","article-title":"Anti-cancer effects of ginsenoside CK on acute myeloid leukemia in vitro and in vivo","volume":"8","author":"Hou","year":"2022","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.biopha.2024.117440_bib9","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.fct.2011.03.021","article-title":"Inhibition of JAK1\/STAT3 signaling mediates compound K-induced apoptosis in human multiple myeloma U266 cells","volume":"49","author":"Park","year":"2011","journal-title":"Food Chem. Toxicol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117440_bib10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3343\/alm.2019.39.6.580","article-title":"Fluoranthene-induced cytotoxicity and direct effect of aryl hydrocarbon receptor antagonist on hematopoietic stem cell differentiation","volume":"39","author":"Yang","year":"2019","journal-title":"Ann. Lab Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222401326X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222401326X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:16:33Z","timestamp":1773969393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222401326X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":10,"alternative-id":["S075333222401326X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117440","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic effect and molecular mechanism of the ultra-low molecule compound K on multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117440"}}